Physician profile
Ava Star
NPI 1063739951
$2,361.51
in general payments reported to CMS, 2019-2025
10 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,080 · 2020: $302 · 2021: $32.51 · 2022: $497 · 2024: $290 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $290 · Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $290.00 |
| Food and Beverage | $160.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $976.32 | 2019 | |
| W. L. Gore & Associates, INC. | $553.14 | 2020-2025 | Product In Development, Gore Viatorr Tips Endoprosthesis |
| Stryker Corporation | $447.57 | 2022 | |
| Penumbra, INC. | $103.18 | 2019 | |
| Philips North America LLC | $82.56 | 2020 | |
| Cardiovascular Systems INC. | $78.40 | 2020 | |
| Angiodynamics, INC. | $47.08 | 2021-2022 | |
| Terumo Medical Corporation | $34.55 | 2022 | |
| Bard Peripheral Vascular, INC. | $26.12 | 2020 | |
| Tactile Systems Technology INC | $12.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ava Star listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.